te-031 tablets each containing 50 mg potency , were administered to 49 subjects with ages from 3 year and a month to 14 years consisting of 8 cases with pharyngitis , 1 with tonsillitis , 1 with acute bronchitis , 4 with pneumonia , 14 with mycoplasmal pneumonia , 4 with scarlet fever , 5 with campylobacter enteritis , 7 with impetigo , 1 with atypical pneumonia , 1 with salmonella gastroenteritis and 3 with acute enteritis caused by unidentified pathogens , at an average daily dose of 13.5 mg/kg dived into 2-4 doses ( 2 doses/day for 12 cases , 3 doses for 32 , 4 doses for 5 ) for 7 days on the average .
C0031350
pharyngitis
C0040425
tonsillitis